A high-content flow cytometry and dual CRISPR-Cas9 based platform to quantify genetic interactions

Natasha Ramakrishnan1, Taylor Malachowski1, Priyanka Verma1

  • 1Division of Oncology, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States.

Methods in Cell Biology
|February 15, 2024
PubMed
Summary

This study introduces a novel flow-based CRISPR screen to study gene interactions. The method overcomes limitations of traditional screens, enabling precise analysis of genetic interactions and their impact on cell viability over time.